S-C05 Monitoring and Prevention of Relapse after Allogeneic HCT for Myeloid Malignancies

Track: BMT Tandem "Scientific" Meeting
Thursday, February 2, 2012: 10:30 AM-12:00 PM
Elizabeth Ballroom DE (Manchester Grand Hyatt)
Chair:
Michael R. Bishop, MD
Summary:

Concurrent Session 5

Strategies for the Prevention of Relapse in Adult Patients with Myeloid Malignancy Undergoing Allogeneic HCT
Michael R. Bishop, MD, University of Chicago

Methods for Monitoring Minimal Residual Pre- and Post-Allogeneic HCT in Patients with Myeloid Malignancies
Ulrike Bacher, MD, University Medical Center Hamburg-Eppendorf

Strategies for the Prevention of Relapse in Pediatric Patients with Myeloid Malignancy Undergoing Allogeneic HCT
Julie-An Talano, MD, Children's Hospital of Wisconsin

See more of: BMT Tandem "Scientific" Meeting
<< Previous Session | Next Session >>